Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/8980
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
Euro Surveill. 2019 Feb;24(8).
Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34-38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.
Europe | influenza | multicentre study | test-negative design | vaccination | vaccine effectiveness | vaccines and immunisation
Files in this item
- Interim201819InfluenzaVaccine_ ...